Development of medicines for rare diseases: where are the problems?

L. Fregonese (London, United Kingdom)

Source: International Congress 2014 – Ceremony for the ERS Rare Pulmonary Disease Research Award 2014 followed by the symposium "Challenges in endpoints for rare lung diseases"

Slide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Fregonese (London, United Kingdom). Development of medicines for rare diseases: where are the problems?. International Congress 2014 – Ceremony for the ERS Rare Pulmonary Disease Research Award 2014 followed by the symposium "Challenges in endpoints for rare lung diseases"

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Mainstreaming research for rare diseases
Source: Research Seminar 2013 - ERS Presidential Summit on Research gaps, patient needs and innovative solutions: a forward look on lung health research
Year: 2013



Infections in children: is there an underlying rare disease?
Source: International Congress 2019 – Part I: Prevention and management of respiratory infections in primary care.
Year: 2019


Rare pulmonary diseases: a common fight
Source: Eur Respir Rev, 26 (145) 170059; 10.1183/16000617.0059-2017
Year: 2017



Asthma: a complex syndrome of many diseases?
Source: International Congress 2014 – ME09 Asthma: a complex syndrome of many diseases?
Year: 2014




Multidisciplinary approach to systemic diseases: benefits for diagnosis and management of complex disorders
Source: Eur Respir Monogr 2019; 86: 1-13
Year: 2019


Rare lung diseases in children: challenges for diagnosis and treatment
Source: Virtual Congress 2021 – Rare lung diseases 2021
Year: 2021


Future perspectives on rare pulmonary diseases and rare presentations of common disorders},
Source: Eur Respir Rev 2013; 22: 199-201
Year: 2013


Rare pulmonary diseases and orphan drugs: where do we stand and where are we going to?
Source: Eur Respir Rev 2015; 24: 375-377
Year: 2015


The disease burden of mild asthma: Findings from a 2013 real world survey
Source: International Congress 2016 – Asthma and allergy in infancy: from risk factors to mortality
Year: 2016


Tuberculosis: is it still the main etiology of haemoptysis in developing countries?
Source: Annual Congress 2009 - Epidemiology of COPD and infectious lung diseases
Year: 2009


Treating asthma in developing countries: is this a question of money?
Source: Eur Respir J 2005; 26: Suppl. 49, 274s
Year: 2005

Inappropriate asthma therapy: A tale of two countries
Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life
Year: 2016

Skilled manpower assistance for management of chronic respiratory diseases (CRDs): Does India really need it?
Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care
Year: 2015


MDR-/XDR-TB: what are the unresolved problems in the clinical management?
Source: Annual Congress 2012 - PG7 TB and MDR-/XDR-TB: what is new in diagnosis, treatment and follow-up (TB PAN-NET)
Year: 2012



Advocacy in respiratory medicine: Chronic diseases
Source: ERS Summit on priorities in respiratory medicine 2011
Year: 2011


Physician perspectives: barriers to diagnosing and treating severe AATD
Source: International Congress 2017 – Clinical challenges in chronic lung diseases
Year: 2017


Granulomatous lung disease in common variable immunodeficiency: practical issues and difficulties in diagnosis and management
Source: Eur Respir J 2005; 26: Suppl. 49, 376s
Year: 2005

Facing the challenges of self-management in COPD: how do people adapt to the disease, its symptoms and resulting limitations?
Source: Eur Respir J 2005; 26: Suppl. 49, 310s
Year: 2005

Controversies in care: how should we treat congenital lung malformations?
Source: Annual Congress 2007 - Bronchial and lung malformations: from diagnosis to treatment
Year: 2007


International perspectives on severe asthma: Current and future challenges in patient care
Source: International Congress 2016 – Asthma points to ponder
Year: 2016